Researchers detail possible resistance mechanisms of colorectal cancer to bevacizumab (Avastin) Colorado Cancer Blogs, 28 Oct 2013 Christopher Lieu, MD, and colleagues show that colorectal cancer may resist bevacizumab by switching dependence from VEGF-A to…